A.I. Learns to Write in DNA
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
The New York Times reports that Chinese AI companies are now fielding models nearly as capable as the U.S. industry's best, and the response from Silicon Valley is frank concern. U.S. tech leaders, the Times reports, acknowledge China has closed the capability gap faster than they anticipated.
Export controls aimed at slowing China's AI development and the flow of talent out of Chinese research labs were supposed to buy American companies time. According to the Times, neither measure delivered the expected advantage — the margin between the two countries' frontier models has narrowed enough to prompt strategic reassessments at companies including OpenAI, Google, and Anthropic.
This doesn't mean America has lost the race. The Times frames it as America's race to lose — an acknowledgment of continued U.S. leadership paired with a clear-eyed read of eroding advantage. The competitive distance that once felt comfortable has become uncomfortable.
The downstream effects are already visible in how the biggest American AI labs approach model development, partnerships, and government relations. When the margin is wide, you can afford to optimize; when it's thin, every decision about resources and priorities sharpens.
All comments are reviewed before appearing. Keep it respectful.
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
The Trump administration has no idea on how to handle open-source and open-weight AI models from China.
Google is consolidating AI leadership in California but the reorganization is pushing out the engineers who built its AI division